Bausch Health Companies Inc. (BHC)

NYSE: BHC · Real-Time Price · USD

5.17

+0.06 (1.17%)

At close: Jun 9, 2026, 4:00 PM EDT

5.17

0.00 (0.00%)

Pre-market: Jun 10, 2026, 4:47 AM EDT

Bausch Health Companies Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-1,258	87.43	-50.17	-461.13	-212	-937
Depreciation & Amortization	870.11	880.11	882.88	953.97	1,394	1,552
Stock-Based Compensation	166.37	157.37	104.52	99.62	126	128
Other Adjustments	1,597	217.11	337.96	640.76	-66	1,178
Change in Receivables	-59.63	-97.63	-150.52	-147.17	-57	-229
Changes in Inventories	7.26	-8.74	-186.05	-243.02	-198	-16
Changes in Accounts Payable	-106.37	-55.37	248.77	119.25	-75	121
Changes in Other Operating Activities	-284.29	-160.29	-74.56	-183.4	-1,640	-371
Operating Cash Flow	1,039	1,020	1,113	778.87	-728	1,426
Operating Cash Flow Growth	-6.63%	-8.34%	42.88%	-	-	28.35%
Capital Expenditures	-283.24	-289.24	-234.83	-162.27	-218	-269
Purchases of Intangible Assets	-36.29	-7.29	-2.09	-43.02	-50	-14
Purchases of Investments	-5.01	-8.01	-8.36	-20.38	-17	-19
Proceeds from Sale of Investments	2.83	5.83	9.76	19.62	22	15
Payments for Business Acquisitions	-136.63	-148.63	-94.77	-1,426	-45	-
Proceeds from Business Divestments	8.1	5.1	4.88	3.77	5	669
Other Investing Activities	7.74	8.74	9.06	9.81	-	27
Investing Cash Flow	-442.5	-433.5	-316.36	-1,619	-303	409
Long-Term Debt Issued	10,441	7,689	460.6	2,484	6,836	2,100
Long-Term Debt Repaid	-10,842	-8,153	-1,017	-1,291	-7,846	-3,440
Net Long-Term Debt Issued (Repaid)	-401.1	-464.1	-556.77	1,193	-1,010	-1,340
Issuance of Common Stock	-	-	-	-	675	-
Net Common Stock Issued (Repurchased)	-	-	-	-	675	-
Other Financing Activities	-93.5	-76.5	-48.08	-80	-139	-173
Financing Cash Flow	-494.6	-540.6	-604.85	1,113	-474	-1,513
Effect of Exchange Rate Changes on Cash and Cash Equivalents	19.44	44.44	-25.09	6.79	-23	-19
Net Cash Flow	121.34	90.34	166.54	280	-1,528	303
Free Cash Flow	755.75	730.75	878	616.61	-946	1,157
Free Cash Flow Growth	3.42%	-16.77%	42.39%	-	-	43.02%
FCF Margin	6.36%	7.12%	9.12%	7.04%	-11.64%	13.72%
Free Cash Flow Per Share	2.02	1.95	2.39	1.69	-2.61	3.22
Levered Free Cash Flow	-1,380	59.37	33.44	1,086	-1,972	-1,271
Unlevered Free Cash Flow	734.6	3,400	4,395	901.83	-575.11	1,505

SEC Filings: 10-K · 10-Q